Is non-adherence to treatment associated with visual acuity loss in patients with AMD, DME, and BRVO?
Non-adherence to treatment regimens is a significant risk factor for visual acuity loss, especially in patients with diabetic macular edema.
NA to treatment and follow-up regimens is a common problem in the management of patients with AMD and DME and limits clinical treatment outcomes under real-life conditions. Patients with DME have the highest risk of patient-associated NA, associated with a higher risk for significant VA loss.
Ehlken et al. (Fri,) studied this question.